MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 137 filers reported holding MERSANA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $428,057 | -90.7% | 337,053 | -75.9% | 0.00% | -100.0% |
| Q2 2023 | $4,592,899 | -62.0% | 1,396,018 | -52.5% | 0.00% | -66.7% |
| Q1 2023 | $12,081,509 | +2.3% | 2,939,540 | +45.9% | 0.00% | 0.0% |
| Q4 2022 | $11,804,947 | -27.4% | 2,014,496 | -16.2% | 0.00% | -25.0% |
| Q3 2022 | $16,250,000 | +89.1% | 2,403,969 | +29.2% | 0.00% | +100.0% |
| Q2 2022 | $8,595,000 | +30.5% | 1,860,347 | +12.7% | 0.00% | +100.0% |
| Q1 2022 | $6,586,000 | -12.5% | 1,650,752 | +36.5% | 0.00% | 0.0% |
| Q4 2021 | $7,524,000 | -30.3% | 1,209,612 | +5.6% | 0.00% | -50.0% |
| Q3 2021 | $10,801,000 | +37.9% | 1,145,369 | +98.5% | 0.00% | 0.0% |
| Q2 2021 | $7,835,000 | -58.2% | 576,955 | -50.2% | 0.00% | -60.0% |
| Q1 2021 | $18,727,000 | -32.3% | 1,157,390 | +11.3% | 0.01% | -28.6% |
| Q4 2020 | $27,659,000 | +149.2% | 1,039,447 | +74.4% | 0.01% | +133.3% |
| Q3 2020 | $11,101,000 | +4.9% | 596,169 | +31.8% | 0.00% | 0.0% |
| Q2 2020 | $10,585,000 | +2017.0% | 452,360 | +427.9% | 0.00% | – |
| Q1 2020 | $500,000 | +35.9% | 85,690 | +33.3% | 0.00% | – |
| Q4 2019 | $368,000 | +217.2% | 64,291 | -12.1% | 0.00% | – |
| Q3 2019 | $116,000 | -29.3% | 73,103 | +80.3% | 0.00% | – |
| Q2 2019 | $164,000 | +28.1% | 40,549 | +67.1% | 0.00% | – |
| Q1 2019 | $128,000 | +5.8% | 24,261 | -17.9% | 0.00% | – |
| Q4 2018 | $121,000 | -64.0% | 29,557 | -12.0% | 0.00% | – |
| Q3 2018 | $336,000 | +36.0% | 33,592 | +143.3% | 0.00% | – |
| Q2 2018 | $247,000 | -35.2% | 13,809 | -42.9% | 0.00% | – |
| Q1 2018 | $381,000 | +54.3% | 24,190 | +61.0% | 0.00% | – |
| Q4 2017 | $247,000 | -64.7% | 15,023 | -70.0% | 0.00% | – |
| Q2 2017 | $699,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |